• New Approaches to IBS and IBD, But Concerns About PPIs, Highlighted at DDW

New Approaches to IBS and IBD, But Concerns About PPIs, Highlighted at DDW

A new test to identify diarrhea-predominant irritable bowel syndrome (D-IBS) and a new class of drugs to treat ulcerative colitis were presented at Digestive Disease Week (DDW) in Washington DC, May 15–19. Researchers also warned that many residents of nursing homes are being inappropriately given proton pump inhibitors (PPIs). Mark Pimentel

Read more
  • Video: Which Patients with Crohn’s Disease Need a CT Scan?

Video: Which Patients with Crohn’s Disease Need a CT Scan?

Researchers have developed a system to identify patients with Crohn’s disease who do not require computed tomography (CT) evaluation, described by Shail M. Govani et al  in the October issue of Clinical Gastroenterology and Hepatology. The system uses laboratory test results to avoid CT analysis, and thereby unnecessary exposure to radiation and increased cancer risk. People who come to the emergency department with

Read more
  • Measuring MicroRNAs to Detect Pancreatic Cancer

Measuring MicroRNAs to Detect Pancreatic Cancer

Analysis of microRNAs improves cytologic analysis of pancreatic fine-needle aspirates, allowing for more accurate identification of patients with pancreatic ductal adenocarcinoma (PDAC), researchers report in the October issue of Clinical Gastroenterology and Hepatology. This improvement could reduce the number of diagnostic procedures required for patients with pancreatic masses. Endoscopic ultrasound–guided fine-needle

Read more

Does EGD Identify Causes of Abdominal Pain in Children?

Esophagogastroduodenoscopy (EGD) is a useful tool for the diagnosis of children with abdominal pain, researchers report in the June issue of Clinical Gastroenterology and Hepatology. The procedure identified disorders for which medical therapy was effective in 67% of children. Chronic abdominal pain is the most common indication for EGD in children.

Read more
  • Cancer Cells in Circulation

Cancer Cells in Circulation

Pancreatic cancer cells can be detected in patients’ circulation before tumors are discovered, researchers report in the March issue of Gastroenterology. Cancer cells have long been believed to acquire metastatic potential after large primary tumors are established. However, many patients undergoing pancreatectomy for chronic pancreatitis are found to have disseminated pancreatic

Read more

Does a Response to Proton Pump Inhibitor Therapy Indicate GERD?

Just because a patient’s upper gastrointestinal symptoms are alleviated by proton pump inhibitors (PPIs) doesn’t necessarily mean that they have gastroesophageal reflux disease (GERD), according to the December issue of Clinical Gastroenterology and Hepatology. The efficacy of PPI therapy often is tested to determine whether patients’ symptoms are acid-related and

Read more

Which Direction is Best for Enteroscopy?

Antegrade is better than retrograde enteroscopy in diagnosis and treatment of patients with small bowel disease, according to the August issue of Clinical Gastroenterology and Hepatology. Single and double balloon-assisted enteroscopy (SBE and DBE), and spiral enteroscopy (which uses a screw-like overtube), are used to evaluate and treat patients with

Read more

Why Do Only Some Gastric Tumors Respond to Therapy?

Tumors from patients with gastric cancer can be divided into subgroups, based on their gene expression pattern. This information can be used to select the best treatment, according to Patrick Tan and colleagues in the August issue of Gastroenterology. Gastric tumors have large, inter-individual differences in aggressiveness, histopathology features, and

Read more

Tracking Pancreatic Cancer Cells

Tumors spread to other parts of the body when cancer cells can escape into the bloodstream, although it is not exactly clear how they enter the circulation or decide where to form new tumors. Andrew Rhim and colleagues at the University of Pennsylvania have developed a technology to label tumor

Read more

Are Biopsies Safe for Patients with Advanced Liver Disease?

Liver biopsies are relatively safe and well tolerated among patients with advanced chronic hepatitis C, based on data from the HALT-C trial.  Liver biopsy analysis provides information for diagnosis and planning of treatment strategies for patients with acute and chronic liver diseases, such as chronic hepatitis C infection. However, biopsies

Read more